Safer Compounding in Hospitals Act of 2024

This bill amends the Social Security Act to create a Medicare add-on payment for hospitals that use automated technology to prepare sterile intravenous drugs, aiming to improve safety and accuracy for beneficiaries.

Sec. 2, Promoting preparedness and Medicare beneficiary access to safer, more accurate sterile intravenous drug preparations through automated hospital infrastructure: For discharges from October 1, 2025, through September 30, 2031, Medicare will pay an additional $40 to a hospital for each sterile intravenous treatment prepared using a closed system automation device that meets FDA requirements. The Health and Human Services Secretary will identify these treatments using ICD-10-PCS codes or other methods. The Secretary must adjust payments to keep total Medicare spending neutral, and total extra payments per fiscal year cannot exceed $40 million. The bill defines a closed system automation device as FDA-cleared or approved equipment that aseptically compounds sterile preparations without direct human handling, maintains an ISO 5 environment, uses barcode verification of FDA-approved drug ingredients, ensures dose accuracy with gravimetric analysis, provides photographic evidence of supply containers, labels within the ISO 5 environment, keeps detailed records, and is developed as a pharmacy compounding device per FDA guidance.